{"id":4646,"date":"2024-09-09T14:12:21","date_gmt":"2024-09-09T04:12:21","guid":{"rendered":"\/eu-uk\/?p=4646"},"modified":"2024-09-10T14:13:14","modified_gmt":"2024-09-10T04:13:14","slug":"proactive-interview-with-john-van-der-wielen","status":"publish","type":"post","link":"\/eu-uk\/blog\/2024\/09\/09\/proactive-interview-with-john-van-der-wielen\/","title":{"rendered":"Proactive | Interview with John Van Der Wielen"},"content":{"rendered":"<p>Following the Company&#8217;s\u00a0announcement last week confirming the first sales of Striate+ in Canada, Orthocell&#8217;s Chairman John Van Der Wielen spoke with Proactive\u2019s Tylah Tully about the Company&#8217;s swift transition from regulatory approval to sales in the Canadian market, and plans to expand into the Singapore and Brazil markets within the next six to 12 months.<\/p>\n<p>Take a look:<\/p>\n<p><iframe loading=\"lazy\" title=\"YouTube video player\" src=\"https:\/\/www.youtube.com\/embed\/TcGfmax5674?si=a0i0AZAyiPo0Ih-r\" width=\"560\" height=\"315\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Following the Company&#8217;s\u00a0announcement last week confirming the first sales of Striate+ in Canada, Orthocell&#8217;s Chairman John Van Der Wielen spoke with Proactive\u2019s Tylah Tully about the Company&#8217;s swift transition from regulatory approval to sales in the Canadian market, and plans to expand into the Singapore and Brazil markets within the next six to 12 months.<\/p>\n","protected":false},"author":2,"featured_media":4647,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-4646","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-video"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 4.9.8 - aioseo.com -->\n\t<meta name=\"description\" content=\"Following the Company&#039;s announcement last week confirming the first sales of Striate+ in Canada, Orthocell&#039;s Chairman John Van Der Wielen spoke with Proactive\u2019s Tylah Tully about the Company&#039;s swift transition from regulatory approval to sales in the Canadian market, and plans to expand into the Singapore and Brazil markets within the next six to 12 months.\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"Orthocell\"\/>\n\t<link rel=\"canonical\" href=\"\/eu-uk\/blog\/2024\/09\/09\/proactive-interview-with-john-van-der-wielen\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 4.9.8\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_GB\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Orthocell EU\/UK -\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Proactive | Interview with John Van Der Wielen - Orthocell EU\/UK\" \/>\n\t\t<meta property=\"og:description\" content=\"Following the Company&#039;s announcement last week confirming the first sales of Striate+ in Canada, Orthocell&#039;s Chairman John Van Der Wielen spoke with Proactive\u2019s Tylah Tully about the Company&#039;s swift transition from regulatory approval to sales in the Canadian market, and plans to expand into the Singapore and Brazil markets within the next six to 12 months.\" \/>\n\t\t<meta property=\"og:url\" content=\"\/eu-uk\/blog\/2024\/09\/09\/proactive-interview-with-john-van-der-wielen\/\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2024-09-09T04:12:21+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2024-09-10T04:13:14+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Proactive | Interview with John Van Der Wielen - Orthocell EU\/UK\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Following the Company&#039;s announcement last week confirming the first sales of Striate+ in Canada, Orthocell&#039;s Chairman John Van Der Wielen spoke with Proactive\u2019s Tylah Tully about the Company&#039;s swift transition from regulatory approval to sales in the Canadian market, and plans to expand into the Singapore and Brazil markets within the next six to 12 months.\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2024\\\/09\\\/09\\\/proactive-interview-with-john-van-der-wielen\\\/#blogposting\",\"name\":\"Proactive | Interview with John Van Der Wielen - Orthocell EU\\\/UK\",\"headline\":\"Proactive | Interview with John Van Der Wielen\",\"author\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/author\\\/hcartres\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/wp-content\\\/uploads\\\/sites\\\/6\\\/2024\\\/09\\\/Proactive.png\",\"width\":1000,\"height\":714},\"datePublished\":\"2024-09-09T14:12:21+10:00\",\"dateModified\":\"2024-09-10T14:13:14+10:00\",\"inLanguage\":\"en-GB\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2024\\\/09\\\/09\\\/proactive-interview-with-john-van-der-wielen\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2024\\\/09\\\/09\\\/proactive-interview-with-john-van-der-wielen\\\/#webpage\"},\"articleSection\":\"Video\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2024\\\/09\\\/09\\\/proactive-interview-with-john-van-der-wielen\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/category\\\/video\\\/#listItem\",\"name\":\"Video\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/category\\\/video\\\/#listItem\",\"position\":2,\"name\":\"Video\",\"item\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/category\\\/video\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2024\\\/09\\\/09\\\/proactive-interview-with-john-van-der-wielen\\\/#listItem\",\"name\":\"Proactive | Interview with John Van Der Wielen\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2024\\\/09\\\/09\\\/proactive-interview-with-john-van-der-wielen\\\/#listItem\",\"position\":3,\"name\":\"Proactive | Interview with John Van Der Wielen\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/category\\\/video\\\/#listItem\",\"name\":\"Video\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/#organization\",\"name\":\"Orthocell EU\\\/UK\",\"url\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/author\\\/hcartres\\\/#author\",\"url\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/author\\\/hcartres\\\/\",\"name\":\"Orthocell\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2024\\\/09\\\/09\\\/proactive-interview-with-john-van-der-wielen\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0aab809366bb46167bf34d1c56223f53c568b96a5870f19d01139e3e4a20c2f1?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"Orthocell\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2024\\\/09\\\/09\\\/proactive-interview-with-john-van-der-wielen\\\/#webpage\",\"url\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2024\\\/09\\\/09\\\/proactive-interview-with-john-van-der-wielen\\\/\",\"name\":\"Proactive | Interview with John Van Der Wielen - Orthocell EU\\\/UK\",\"description\":\"Following the Company's announcement last week confirming the first sales of Striate+ in Canada, Orthocell's Chairman John Van Der Wielen spoke with Proactive\\u2019s Tylah Tully about the Company's swift transition from regulatory approval to sales in the Canadian market, and plans to expand into the Singapore and Brazil markets within the next six to 12 months.\",\"inLanguage\":\"en-GB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2024\\\/09\\\/09\\\/proactive-interview-with-john-van-der-wielen\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/author\\\/hcartres\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/author\\\/hcartres\\\/#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/wp-content\\\/uploads\\\/sites\\\/6\\\/2024\\\/09\\\/Proactive.png\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2024\\\/09\\\/09\\\/proactive-interview-with-john-van-der-wielen\\\/#mainImage\",\"width\":1000,\"height\":714},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2024\\\/09\\\/09\\\/proactive-interview-with-john-van-der-wielen\\\/#mainImage\"},\"datePublished\":\"2024-09-09T14:12:21+10:00\",\"dateModified\":\"2024-09-10T14:13:14+10:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/#website\",\"url\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/\",\"name\":\"Orthocell EU\\\/UK\",\"inLanguage\":\"en-GB\",\"publisher\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Proactive | Interview with John Van Der Wielen - Orthocell EU\/UK","description":"Following the Company's announcement last week confirming the first sales of Striate+ in Canada, Orthocell's Chairman John Van Der Wielen spoke with Proactive\u2019s Tylah Tully about the Company's swift transition from regulatory approval to sales in the Canadian market, and plans to expand into the Singapore and Brazil markets within the next six to 12 months.","canonical_url":"\/eu-uk\/blog\/2024\/09\/09\/proactive-interview-with-john-van-der-wielen\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"\/eu-uk\/blog\/2024\/09\/09\/proactive-interview-with-john-van-der-wielen\/#blogposting","name":"Proactive | Interview with John Van Der Wielen - Orthocell EU\/UK","headline":"Proactive | Interview with John Van Der Wielen","author":{"@id":"\/eu-uk\/blog\/author\/hcartres\/#author"},"publisher":{"@id":"\/eu-uk\/#organization"},"image":{"@type":"ImageObject","url":"\/eu-uk\/wp-content\/uploads\/sites\/6\/2024\/09\/Proactive.png","width":1000,"height":714},"datePublished":"2024-09-09T14:12:21+10:00","dateModified":"2024-09-10T14:13:14+10:00","inLanguage":"en-GB","mainEntityOfPage":{"@id":"\/eu-uk\/blog\/2024\/09\/09\/proactive-interview-with-john-van-der-wielen\/#webpage"},"isPartOf":{"@id":"\/eu-uk\/blog\/2024\/09\/09\/proactive-interview-with-john-van-der-wielen\/#webpage"},"articleSection":"Video"},{"@type":"BreadcrumbList","@id":"\/eu-uk\/blog\/2024\/09\/09\/proactive-interview-with-john-van-der-wielen\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/orthocell.com\/eu-uk#listItem","position":1,"name":"Home","item":"https:\/\/orthocell.com\/eu-uk","nextItem":{"@type":"ListItem","@id":"\/eu-uk\/blog\/category\/video\/#listItem","name":"Video"}},{"@type":"ListItem","@id":"\/eu-uk\/blog\/category\/video\/#listItem","position":2,"name":"Video","item":"\/eu-uk\/blog\/category\/video\/","nextItem":{"@type":"ListItem","@id":"\/eu-uk\/blog\/2024\/09\/09\/proactive-interview-with-john-van-der-wielen\/#listItem","name":"Proactive | Interview with John Van Der Wielen"},"previousItem":{"@type":"ListItem","@id":"https:\/\/orthocell.com\/eu-uk#listItem","name":"Home"}},{"@type":"ListItem","@id":"\/eu-uk\/blog\/2024\/09\/09\/proactive-interview-with-john-van-der-wielen\/#listItem","position":3,"name":"Proactive | Interview with John Van Der Wielen","previousItem":{"@type":"ListItem","@id":"\/eu-uk\/blog\/category\/video\/#listItem","name":"Video"}}]},{"@type":"Organization","@id":"\/eu-uk\/#organization","name":"Orthocell EU\/UK","url":"\/eu-uk\/"},{"@type":"Person","@id":"\/eu-uk\/blog\/author\/hcartres\/#author","url":"\/eu-uk\/blog\/author\/hcartres\/","name":"Orthocell","image":{"@type":"ImageObject","@id":"\/eu-uk\/blog\/2024\/09\/09\/proactive-interview-with-john-van-der-wielen\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/0aab809366bb46167bf34d1c56223f53c568b96a5870f19d01139e3e4a20c2f1?s=96&d=mm&r=g","width":96,"height":96,"caption":"Orthocell"}},{"@type":"WebPage","@id":"\/eu-uk\/blog\/2024\/09\/09\/proactive-interview-with-john-van-der-wielen\/#webpage","url":"\/eu-uk\/blog\/2024\/09\/09\/proactive-interview-with-john-van-der-wielen\/","name":"Proactive | Interview with John Van Der Wielen - Orthocell EU\/UK","description":"Following the Company's announcement last week confirming the first sales of Striate+ in Canada, Orthocell's Chairman John Van Der Wielen spoke with Proactive\u2019s Tylah Tully about the Company's swift transition from regulatory approval to sales in the Canadian market, and plans to expand into the Singapore and Brazil markets within the next six to 12 months.","inLanguage":"en-GB","isPartOf":{"@id":"\/eu-uk\/#website"},"breadcrumb":{"@id":"\/eu-uk\/blog\/2024\/09\/09\/proactive-interview-with-john-van-der-wielen\/#breadcrumblist"},"author":{"@id":"\/eu-uk\/blog\/author\/hcartres\/#author"},"creator":{"@id":"\/eu-uk\/blog\/author\/hcartres\/#author"},"image":{"@type":"ImageObject","url":"\/eu-uk\/wp-content\/uploads\/sites\/6\/2024\/09\/Proactive.png","@id":"\/eu-uk\/blog\/2024\/09\/09\/proactive-interview-with-john-van-der-wielen\/#mainImage","width":1000,"height":714},"primaryImageOfPage":{"@id":"\/eu-uk\/blog\/2024\/09\/09\/proactive-interview-with-john-van-der-wielen\/#mainImage"},"datePublished":"2024-09-09T14:12:21+10:00","dateModified":"2024-09-10T14:13:14+10:00"},{"@type":"WebSite","@id":"\/eu-uk\/#website","url":"\/eu-uk\/","name":"Orthocell EU\/UK","inLanguage":"en-GB","publisher":{"@id":"\/eu-uk\/#organization"}}]},"og:locale":"en_GB","og:site_name":"Orthocell EU\/UK -","og:type":"article","og:title":"Proactive | Interview with John Van Der Wielen - Orthocell EU\/UK","og:description":"Following the Company's announcement last week confirming the first sales of Striate+ in Canada, Orthocell's Chairman John Van Der Wielen spoke with Proactive\u2019s Tylah Tully about the Company's swift transition from regulatory approval to sales in the Canadian market, and plans to expand into the Singapore and Brazil markets within the next six to 12 months.","og:url":"\/eu-uk\/blog\/2024\/09\/09\/proactive-interview-with-john-van-der-wielen\/","article:published_time":"2024-09-09T04:12:21+00:00","article:modified_time":"2024-09-10T04:13:14+00:00","twitter:card":"summary_large_image","twitter:title":"Proactive | Interview with John Van Der Wielen - Orthocell EU\/UK","twitter:description":"Following the Company's announcement last week confirming the first sales of Striate+ in Canada, Orthocell's Chairman John Van Der Wielen spoke with Proactive\u2019s Tylah Tully about the Company's swift transition from regulatory approval to sales in the Canadian market, and plans to expand into the Singapore and Brazil markets within the next six to 12 months."},"aioseo_meta_data":[],"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/orthocell.com\/eu-uk\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"\/eu-uk\/blog\/category\/video\/\" title=\"Video\">Video<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tProactive | Interview with John Van Der Wielen\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/orthocell.com\/eu-uk"},{"label":"Video","link":"\/eu-uk\/blog\/category\/video\/"},{"label":"Proactive | Interview with John Van Der Wielen","link":"\/eu-uk\/blog\/2024\/09\/09\/proactive-interview-with-john-van-der-wielen\/"}],"_links":{"self":[{"href":"\/eu-uk\/wp-json\/wp\/v2\/posts\/4646","targetHints":{"allow":["GET"]}}],"collection":[{"href":"\/eu-uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"\/eu-uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/comments?post=4646"}],"version-history":[{"count":1,"href":"\/eu-uk\/wp-json\/wp\/v2\/posts\/4646\/revisions"}],"predecessor-version":[{"id":4648,"href":"\/eu-uk\/wp-json\/wp\/v2\/posts\/4646\/revisions\/4648"}],"wp:featuredmedia":[{"embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/media\/4647"}],"wp:attachment":[{"href":"\/eu-uk\/wp-json\/wp\/v2\/media?parent=4646"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/categories?post=4646"},{"taxonomy":"post_tag","embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/tags?post=4646"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}